Open Philanthropy recommended a grant of $1,600,000 over three years to the Oxfendazole Development Group to support their work conducting animal toxicity tests for oxfendazole, a veterinary deworming medicine, as part of a larger project focused on getting it approved to treat whipworm and other human parasitic diseases.
This falls within Open Philanthropy’s focus area of scientific research, specifically within its interest in advancing human health and wellbeing.